The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Prevention of fat-induced insulin resistance by salicylate
Open accessAbstract
Insulin resistance is a major factor in the pathogenesis of type 2 diabetes and may involve fat-induced activation of a serine kinase cascade involving IKK-beta. To test this hypothesis, we first examined insulin action and signaling in awake rats during hyperinsulinemic-euglycemic clamps after a lipid infusion with or without pretreatment with salicylate, a known inhibitor of IKK-beta. Whole-body glucose uptake and metabolism were estimated using [3-(3)H]glucose infusion, and glucose uptake in individual tissues was estimated using [1-(14)C]2-deoxyglucose injection during the clamp. Here we show that lipid infusion decreased insulin-stimulated glucose uptake and activation of IRS-1-associated PI 3-kinase in skeletal muscle but that salicylate pretreatment prevented these lipid-induced effects. To examine the mechanism of salicylate action, we studied the effects of lipid infusion on insulin action and signaling during the clamp in awake mice lacking IKK-beta. Unlike the response in wild-type mice, IKK-beta knockout mice did not exhibit altered skeletal muscle insulin signaling and action following lipid infusion. In summary, high-dose salicylate and inactivation of IKK-beta prevent fat-induced insulin resistance in skeletal muscle by blocking fat-induced defects in insulin signaling and action and represent a potentially novel class of therapeutic agents for type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As described above, there is substantial local production of inflammatory mediators in organs affected by insulin resistance.”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [67]
In the citing paper
“On the other hand, it seems likely that reduced secretion of pro-inflammatory mediators from adipocytes or activated macrophages of adipose tissue contributes to the effect of weight loss (31,36,65,67,142) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [67]
In the citing paper
“Moreover, the insulin resistance was ameliorated with salicylates, which also protected against insulin resistance in rodents after acute lipid infusion,127 and reversed insulin resistance in people with type 2 diabetes mellitus.128”
From Lipid-induced insulin resistance: unravelling the mechanism (2010) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,622
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1210/en.141.6.1930 · DOI
Cited by
Sorted by citations
Items 101–200 of 738
Titchenell, P. M., Quinn, W. J., Lu, M., Chu, Q., Lu, W., Li, C., Chen, H., Monks, B. R., Chen, J., Rabinowitz, J. D., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.022 · Cited by 298
Corbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283
Self-citationFinck, B. N., Bernal-Mizrachi, C., Han, D. H., Coleman, T., Sambandam, N., LaRiviere, L. L., Holloszy, J. O., Semenkovich, C. F., & Kelly, D. P. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.006 · Cited by 270
Regulation of obesity and insulin resistance by nitric oxide
Sansbury, B. E., & Hill, B. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.016 · Cited by 274
Weigert, C., Brodbeck, K., Staiger, H., Kausch, C., Machicao, F., Häring, H. U., & Schleicher, E. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312692200 · Cited by 269
Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin
Piya, M. K., McTernan, P. G., & Kumar, S. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0498 · Cited by 266
Increased melatonin signaling is a risk factor for type 2 diabetes
Tuomi, T., Nagorny, C. L. F., Singh, P., Bennet, H., Yu, Q., Alenkvist, I., Isomaa, B., Östman, B., Söderström, J., Pesonen, A.-K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.009 · Cited by 262
Gao, Z., Zuberi, A. R., Quon, M. J., Dong, Z., & Ye, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300423200 · Cited by 262
Lipid-Overloaded Enlarged Adipocytes Provoke Insulin Resistance Independent of Inflammation
Kim, J. I., Huh, J. Y., Sohn, J. H., Choe, S. S., Lee, Y. S., Lim, C. Y., Jo, A., Park, S. B., Han, W., & Kim, J. B. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01321-14 · Cited by 272
Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302
Werner, E. D., Lee, J., Hansen, L., Yuan, M., & Shoelson, S. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405203200 · Cited by 257
Mouse models of insulin resistance
Hribal, M. L., Oriente, F., & Accili, D. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2001 · Cited by 251
Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome
Fessler, M. B., Rudel, L. L., & Brown, J. M. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832fa5c4 · Cited by 256
Mouse Models of Insulin Resistance
Nandi, A. A., KITAMURA, Y., Kahn, C. R., & Accili, D. (2004) · Physiological Reviews · doi:10.1152/physrev.00032.2003 · Cited by 249
Tataranni, P. A., & Ortega, E. (2005) · Diabetes · doi:10.2337/diabetes.54.4.917 · Cited by 241
Modulation of the JNK Pathway in Liver Affects Insulin Resistance Status
Nakatani, Y., Kaneto, H., Kawamori, D., Hatazaki, M., Miyatsuka, T., Matsuoka, T., Kajimoto, Y., Matsuhisa, M., Yamasaki, Y., & Hori, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406963200 · Cited by 230
Nagoshi, T., Matsui, T., Aoyama, T., Leri, A., Anversa, P., Li, L., Ogawa, W., del Monte, F., Gwathmey, J. K., Grazette, L. P., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23073 · Cited by 229
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Liu, Q., Bengmark, S., & Qu, S. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-42 · Cited by 233
AMP‐activated protein kinase: role in metabolism and therapeutic implications
Schimmack, G., DeFronzo, R. A., & Musi, N. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00561.x · Cited by 231
Shared dysregulated pathways lead to Parkinson's disease and diabetes
Santiago, J. A., & Potashkin, J. A. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.01.002 · Cited by 232
Kim, J. K., Gimeno, R. E., Higashimori, T., Kim, H., Choi, H., Punreddy, S., Mozell, R. L., Tan, G., Stricker‐Krongrad, A., Hirsch, D. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18917 · Cited by 254
Wullaert, A., Loo, G., Heyninck, K., & Beyaert, R. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0031 · Cited by 221
The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm
Dandona, P., Aljada, A., & Mohanty, P. (2002) · Diabetologia · doi:10.1007/s00125-001-0766-5 · Cited by 218
Cytokines and the pathogenesis of non-alcoholic steatohepatitis
Diehl, A. M., Li, Z. P., Lin, H., & Yang, S. (2005) · Gut · doi:10.1136/gut.2003.024935 · Cited by 217
Salvadó, L., Coll, T., Gómez-Foix, A. M., Salmerón, E., Barroso, E., Palomer, X., & Vázquez‐Carrera, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2867-3 · Cited by 219
Sinha, S., Perdomo, G., Brown, N. F., & O'Doherty, R. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406514200 · Cited by 219
Kim, J. K., Gimeno, R. E., Higashimori, T., Kim, H., Choi, H., Punreddy, S., Mozell, R. L., Tan, G., Stricker‐Krongrad, A., Hirsch, D. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418917 · Cited by 212
Fujimoto, M., Shimizu, N., Kunii, K., Martyn, J. A. J., Ueki, K., & Kaneki, M. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1340 · Cited by 209
López‐Candales, A., Burgos, P. M. H., Hernández-Suárez, D. F., & Harris, D. A. (2017) · PubMed · Cited by 214
Maher, J. J., León, P., & Ryan, J. C. (2008) · Hepatology · doi:10.1002/hep.22399 · Cited by 208
Pathogenic perspectives for the role of inflammation in diabetic nephropathy
Rivero, A., Fernández, C. M., Muros, M., Garcı́a, J. G., Herrera, H., & Navarro‐González, J. F. (2009) · Clinical Science · doi:10.1042/cs20080394 · Cited by 190
Jung, T. W., Lee, S. H., Kim, H.-C., Bang, J. S., Abd El-Aty, A. M., Hacımüftüoğlu, A., Shin, Y. K., & Jeong, J. H. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0147-5 · Cited by 203
Non‐alcoholic steatohepatitis: Definitions and pathogenesis
Day, C., & SAKSENA, S. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s3.31.x · Cited by 187
Beta-glucans in the treatment of diabetes and associated cardiovascular risks
Chen, J. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3803 · Cited by 186
Animal models of steatohepatitis
Koteish, A. A., & Diehl, A. M. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0332 · Cited by 175
Inflammation during obesity is not all bad: evidence from animal and human studies
Ye, J., & McGuinness, O. P. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2012 · Cited by 178
Nonalcoholic steatohepatitis: what we know in the new millennium
Harrison, S. A., Kadakia, S. C., Lang, K. A., & Schenker, S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07069.x · Cited by 185
Zderic, T. W., & Hamilton, M. T. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00925.2005 · Cited by 174
Jové, M., Planavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Endocrinology · doi:10.1210/en.2005-0440 · Cited by 172
Hasegawa, Y., Saito, T., Ogihara, T., Ishigaki, Y., Yamada, T., Imai, J., Uno, K., Gao, J., Kaneko, K., Shimosawa, T., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.054346 · Cited by 169
Lipids and Glucose in Type 2 Diabetes
Boden, G. H., & Laakso, M. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2253 · Cited by 168
Perdomo, L., Beneit, N., Otero, Y. F., Escribano, Ó., Díaz-Castroverde, S., Gómez‐Hernández, A., & Benito, M. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0237-9 · Cited by 177
White, M. F. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-008 · Cited by 164
Adipocyte differentiation induces dynamic changes in NF-κB expression and activity
Berg, A. H., Lin, Y., Lisanti, M. P., & Scherer, P. E. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00002.2004 · Cited by 160
Perdomo, G., Commerford, S. R., Richard, A.-M. T., Adams, S. H., Corkey, B. E., O'Doherty, R. M., & Brown, N. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403566200 · Cited by 158
Lee, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0023-8 · Cited by 161
Aljada, A., Friedman, J., Ghanim, H., Mohanty, P., Hofmeyer, D., Chaudhuri, A., & Dandona, P. (2006) · Metabolism · doi:10.1016/j.metabol.2006.04.016 · Cited by 161
Li, J., Bosch‐Marcé, M., Nanayakkara, A., Savransky, V., Fried, S. K., Semenza, G. L., & Polotsky, V. Y. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00293.2005 · Cited by 168
Role of Heme Oxygenase in Inflammation, Insulin-Signalling, Diabetes and Obesity
Ndisang, J. F. (2010) · Mediators of Inflammation · doi:10.1155/2010/359732 · Cited by 160
Šoškić, S., Dobutović, B. D., Sudar-Milovanovic, E. M., Obradovic, M. M., Nikolić, D., Djordjevic, J. D., Radak, D. J., Mikhailidis, D. P., & Isenović, E. R. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010153 · Cited by 158
Park, J., Choe, S. S., Choi, A. H., Kim, K. H., Yoon, M. J., Suganami, T., Ogawa, Y., & Kim, J. B. (2006) · Diabetes · doi:10.2337/db05-1570 · Cited by 157
Yuan, M., Pino, E. C., Wu, L., Kacergis, M. C., & Soukas, A. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386854 · Cited by 163
Brown, J. M., Betters, J. L., Lord, C. C., Ma, Y., Han, X., Yang, K., Alger, H. M., Melchior, J., Sawyer, J. K., Shah, R., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m010256 · Cited by 157
Effects of Weight Loss and Physical Activity on Muscle Lipid Content and Droplet Size
He, J., Goodpaster, B. H., & Kelley, D. E. (2004) · Obesity Research · doi:10.1038/oby.2004.92 · Cited by 152
Rajala, M. W., Lin, Y., Ranalletta, M., Yang, X. M., Qian, H., Gingerich, R., Barzilai, N., & Scherer, P. E. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0048 · Cited by 153
Lessons from animal models of NASH
Diehl, A. M. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.022 · Cited by 152
Fibrogenic impact of high serum glucose in chro nic hepatitis C
Ratziu, V., Munteanu, M., Charlotte, F., Bonyhay, L., & Poynard, T. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00456-2 · Cited by 151
Coll, T., Jové, M., Rodríguez‐Calvo, R., Eyre, E., Palomer, X., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez‐Carrera, M. (2006) · Diabetes · doi:10.2337/db05-1494 · Cited by 152
Ogihara, T., Asano, T., Katagiri, H., Sakoda, H., Anai, M., Shojima, N., Ono, H., Fujishiro, M., Kushiyama, A., Fukushima, Y., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1391-x · Cited by 151
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Ayala, J. E., Bracy, D. P., Malabanan, C. M., James, F. D., Ansari, T., Fueger, P. T., McGuinness, O. P., & Wasserman, D. H. (2011) · Journal of Visualized Experiments · doi:10.3791/3188 · Cited by 157
Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings
Marette, A. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200207000-00005 · Cited by 151
Shulman, G. I. (2004) · Physiology · doi:10.1152/physiol.00007.2004 · Cited by 152
Hypothalamic dysfunction in obesity
Williams, L. M. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s002966511200078x · Cited by 148
Sriwijitkamol, A., Christ-Roberts, C. Y., Berria, R., Eagan, P. A., Pratipanawatr, T., DeFronzo, R. A., Mandarino, L. J., & Musi, N. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0677 · Cited by 146
Jung, T. W., Hwang, H.-J., Hong, H. C., Yoo, H. J., Baik, S. H., & Choi, K. M. (2015) · Diabetologia · doi:10.1007/s00125-015-3663-z · Cited by 145
Role of T Cells in Malnutrition and Obesity
Gerriets, V. A., & MacIver, N. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00379 · Cited by 154
Keynote review: The adipocyte as a drug discovery target
Nawrocki, A. R., & Scherer, P. E. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03569-5 · Cited by 142
New insights into insulin resistance in the diabetic heart
Gray, S., & Kim, J. K. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.05.001 · Cited by 147
Nawrocki, A. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.003 · Cited by 144
Leucine signaling in the pathogenesis of type 2 diabetes and obesity
Melnik, B. C. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i3.38 · Cited by 141
Diabesity: An Inflammatory Metabolic Condition
Schmidt, M. I., & Duncan, B. B. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.174 · Cited by 140
Püschel, G. P., Klauder, J., & Henkel, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154358 · Cited by 156
Insulin receptor substrate proteins and diabetes
Lee, Y. H., & White, M. F. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980074 · Cited by 136
Predictors and prevention of diabetic cardiomyopathy
Mishra, P. K., Chavali, & Tyagi (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s30968 · Cited by 134
Jové, M., Planavila, A., Laguna, J. C., & Vázquez-Carrera, M. (2005) · Endocrinology · doi:10.1210/en.2004-1560 · Cited by 133
Nitrosative Stress and Pathogenesis of Insulin Resistance
Kaneki, M., Shimizu, N., Yamada, D., & Chang, K. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.1464 · Cited by 136
Jung, T. W., Kim, H., Kim, H. U., Park, T., Park, J., Kim, U., Kim, M. K., & Jeong, J. H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28694 · Cited by 132
Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway
Wang, X., He, G., Peng, Y., Zhong, W., Wang, Y., & Zhang, B. (2015) · Scientific Reports · doi:10.1038/srep12676 · Cited by 127
Muoio, D. M., & Koves, T. R. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-083 · Cited by 129
Molecular mechanisms of lipid‐induced insulin resistance in muscle, liver and vasculature
Krebs, M., & Roden, M. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00439.x · Cited by 130
Goldfine, A. B., Conlin, P. R., Halperin, F., Koška, J., Permana, P. A., Schwenke, D. C., Shoelson, S. E., & Reaven, P. D. (2013) · Diabetologia · doi:10.1007/s00125-012-2819-3 · Cited by 127
Mulder, H., Sörhede‐Winzell, M., Contreras, J. A., Fex, M., Ström, K., Ploug, T., Galbo, H., Arner, P., Lundberg, C., Sundler, F., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213032200 · Cited by 125
Molecular pathways disrupted by gestational diabetes mellitus
Nguyen‐Ngo, C., Jayabalan, N., Salomón, C., & Lappas, M. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0274 · Cited by 129
Radin, M. S., Sinha, S., Bhatt, B. A., Dedousis, N. L., & O'Doherty, R. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0861-3 · Cited by 125
Dandona, P., & Aljada, A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02556-0 · Cited by 121
Koška, J., Ortega, E., Bunt, J. C., Gasser, A., Impson, J., Hanson, R. L., Forbes, J. M., de Courten, B. V., & Krakoff, J. A. (2008) · Diabetologia · doi:10.1007/s00125-008-1239-x · Cited by 122
Husseny, M. W. A. E., Mamdouh, M., Shaban, S., Abushouk, A. I., Zaki, M. M. M., Ahmed, O. M., & Abdel‐Daim, M. M. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8095926 · Cited by 124
Li, Z., & Diehl, A. M. (2003) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200311000-00009 · Cited by 117
Diehl, A. M. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.012 · Cited by 117
Fatty acids and the metabolic syndrome
Roche, H. M. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2004405 · Cited by 113
Kumar, A., Negi, G., & Sharma, S. S. (2012) · Biochimie · doi:10.1016/j.biochi.2012.01.023 · Cited by 113
Aspirin Recapitulates Features of Caloric Restriction
Pietrocola, F., Castoldi, F., Markaki, M., Lachkar, S., Chen, G., Enot, D. P., Durand, S., Bossut, N., Tong, M., Malik, S. A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.024 · Cited by 114
Caputo, T., Gilardi, F., & Desvergne, B. (2017) · FEBS Letters · doi:10.1002/1873-3468.12742 · Cited by 112
Park, S., Kim, D. S., & Kang, S. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0120-0 · Cited by 111
Jiang, G., Dallas-Yang, Q., Li, Z., Szalkowski, D., Liu, F., Shen, X., Wu, M. S., Zhou, G., Doebber, T. W., Berger, J., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2412 · Cited by 106
Insulin resistance: a phosphorylation-based uncoupling of insulin signaling
Zick, Y. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)81297-6 · Cited by 109
Brain insulin and feeding: a bi-directional communication
Gerozissis, K. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.044 · Cited by 108
Role of Cytokines in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
Das, S. K., & Balakrishnan, V. (2011) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-011-0121-7 · Cited by 114
Mechanism for Improved Insulin Sensitivity after Gastric Bypass Surgery
Bikman, B. T., Zheng, D., Pories, W. J., Chapman, W. H. H., Pender, J. R., Bowden, R., Reed, M. A., Cortright, R. N., Tapscott, E. B., Houmard, J. A., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1030 · Cited by 106
IRS proteins and diabetic complications
Lavin, D. P., White, M. F., & Brazil, D. P. (2016) · Diabetologia · doi:10.1007/s00125-016-4072-7 · Cited by 113
Austin, R. L., Rune, A., Bouzakri, K., Zierath, J. R., & Krook, A. (2008) · Diabetes · doi:10.2337/db07-0763 · Cited by 109
Metadata
- Authors
- Kim, J. K., Kim, Y.-J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., Shoelson, S. E., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- Yale University (US)
- Joslin Diabetes Center (US)
- University of California San Diego (US)
- Harvard University (US)
- Corresponding author
- Shulman, Gerald I.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2001-08-01
- Volume
- 108
- Issue
- 3
- Pages
- 437-446
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC209353
- OpenAlex
- W2097838137
- Cited by
- 737
- References
- 55
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 5 · 2023: 7 · 2022: 11 · 2021: 11 · 2020: 12 · 2019: 15 · 2018: 26 · 2017: 23 · 2016: 29 · 2015: 23 · 2014: 26 · 2013: 30 · 2012: 52
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- U.S. Public Health Service (P30 DK45735, R01 DK-40936)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK45735, P30DK045735, DK 51729, U24DK059635, U24DK59635, R01 DK-45493, R01 DK051729, R01DK040936, R01 DK-59635)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, salicylates, IKKβ, type 2 diabetes, lipid infusion, skeletal muscle glucose uptake, IRS-1, PI3-kinase, insulin signaling, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Dietary Fats, Enzyme Inhibitors, Glucose, Infusions, Intravenous, Insulin Resistance, Lipids, Male, Glucose Clamp Technique, Signal Transduction, Rats, Wistar, Protein Serine-Threonine Kinases, Muscle, Skeletal, Salicylic Acid, Rats, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review